Could you elaborate on your thoughts regarding the long-term potential of Haleon shares? Given the company's recent spin-off from GSK, how do you assess its standalone performance and growth prospects? Are there any specific risks or uncertainties that investors should be aware of when considering whether to retain or sell their Haleon shares? Additionally, how does the company's financial health and
market positioning compare to its peers in the industry?
5 answers
Giulia
Sun Aug 04 2024
The Moderate Buy rating is supported by 8 buy ratings, indicating that a majority of analysts believe the stock is undervalued and has the potential to outperform the market.
Stefano
Sun Aug 04 2024
Additionally, 3 hold ratings indicate that some analysts are neutral on Haleon PLC, seeing neither significant upside nor downside potential in the near term. No sell ratings were issued, further underscoring the overall positive sentiment towards the company.
RobertJohnson
Sun Aug 04 2024
Haleon PLC's 12-month average price target, as derived from analyst ratings, stands at 374.27p. This figure represents the market's expectation for the company's share price performance over the next year.
EtherWhale
Sun Aug 04 2024
With an upside potential of 15.34%, Haleon PLC appears to hold significant promise for investors. This potential is based on the analysts' average price target, which suggests that the stock has room to grow in the coming months.
Federico
Sun Aug 04 2024
The consensus rating for Haleon PLC is Moderate Buy, reflecting a positive outlook among analysts. This rating is the result of a comprehensive evaluation of the company's fundamentals, market position, and future prospects.